These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunogenicity and protective role of three formulations of oral cholera vaccine. Kalambaheti T, Chaisri U, Srimanote P, Pongponratn E, Chaicumpa W. Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031 [Abstract] [Full Text] [Related]
5. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens. Chaicumpa W, Parairo JR, New RC, Pongponratn E, Ruangkunaporn Y, Tapchaisri P, Chongsa-nguan M. Asian Pac J Allergy Immunol; 1990 Dec; 8(2):87-94. PubMed ID: 2091663 [Abstract] [Full Text] [Related]
6. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA. Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522 [Abstract] [Full Text] [Related]
9. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children. Taylor DN, Cárdenas V, Perez J, Puga R, Svennerholm AM. Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661 [Abstract] [Full Text] [Related]
10. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. Yeh MK, Liu YT, Chen JL, Chiang CH. J Control Release; 2002 Aug 21; 82(2-3):237-47. PubMed ID: 12175740 [Abstract] [Full Text] [Related]
12. Immunogenicity of Vibrio cholerae O1 fimbriae in animal and human cholera. Ehara M, Ichinose Y, Iwami M, Utsunomiya A, Shimodori S, Kangethe SK, Neves BC, Supawat K, Nakamura S. Microbiol Immunol; 1993 Aug 21; 37(9):679-88. PubMed ID: 7505875 [Abstract] [Full Text] [Related]